A Rare Case of Disseminated Tuberculosis and Hematological Malignancy in a Heart Transplant Recipient.

[1]  G. Bhagat,et al.  The clinical and pathological features of plasma cell myeloma post solid organ transplantation , 2020, American journal of hematology.

[2]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  A. Cowan,et al.  Plasma cell diseases and organ transplant: A comprehensive review , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  V. Dharnidharka.  Comprehensive review of post–organ transplant hematologic cancers , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  P. Moreau,et al.  Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Evens,et al.  Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies , 2013, Current Hematologic Malignancy Reports.

[7]  D. Weisenburger,et al.  Plasma Cell Neoplasms in US Solid Organ Transplant Recipients , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  A. Subramanian,et al.  Mycobacterium tuberculosis Infections in Solid Organ Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  M. Ison,et al.  The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement , 2012, European Respiratory Journal.

[10]  P. Muñoz,et al.  Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. L. Bergsagel,et al.  Genetic aberrations and survival in plasma cell leukemia , 2008, Leukemia.

[12]  A. Singavi,et al.  Post-transplant lymphoproliferative disorders. , 2015, Cancer treatment and research.